Author

Hanan Khoury

Institution: Teva Pharmaceuticals (Israel)

Observed institution: Teva Pharmaceuticals (Israel)

ORCID: 0000-0002-4690-5003

Observed ORCID: 0000-0002-4690-5003

OpenAlex ID: A5070556691

Mitochondrial augmentation of hematopoietic stem cells in children with single large-scale mitochondrial DNA deletion syndromes

2022 · Elad Jacoby, Omer Bar-Yosef, et al. · Science Translational Medicine · 83

Therapeutic potential of mitochondrial transplantation in the treatment of MDS

2025 · Takeshi Fujino, Tina Napso, et al. · Blood

Mitochondrial Augmentation of Hematopoietic Stem and Progenitor Cells As a New Therapeutic Approach for Myelodysplasia

2024 · Takeshi Fujino, Noa Avni, et al. · Blood

Works count: 3

Citation count: 83

H-index: 1

I10-index: 1